Vitamin D supplementation has been primarily studied for its effect on mineral metabolism and, therefore, bone resorption. Vitamin D is also known to play a role in the reninangiotensin-aldosterone system [1] and in inflammation [2] and is produced by vascular endothelial cells [3] . It is, therefore, a strong hypothesis that plasma vitamin D levels influence cardiovascular factors in terms of blood pressure, vascular function and cardiovascular risk. In this issue of Pulse , Veloudi et al. [4] provide a qualitative review of a selection of randomised controlled trials (RCTs) concerning the effect of vitamin D supplementation on blood pressure and measures of arterial stiffness. They also include a descriptive review of some studies concerning cardiovascular outcomes of low serum levels of vitamin D. The article presents a graphical representation of sample size and study duration of 36 studies investigating peripheral blood pressure and 9 studies investigating arterial stiffness. In so doing, the article highlights that very few of these studies show a beneficial effect of vitamin D supplementation. The graphical presentation of the data also allows a visual representation of the previous finding, demonstrated statistically, that there is no relationship between an increased dose of vitamin D supplement and beneficial cardiovascular effect [5] .
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The effect of vitamin D supplementation on cardiovascular factors is of great clinical interest, demonstrated by the number of studies identified in meta-analyses in recent years. This year alone, quantitative meta-analyses of arterial stiffness outcomes have been published by Upala et al. [6] and Rodríguez et al. [7] summarising 7 and 18 RCTs, respectively. A recent quantitative meta-analysis on peripheral blood pressure outcomes identified 46 independent vitamin D supplementation trials [5] . These quantitative studies, although not included in the review by Veloudi et al. [4] , support the same conclusion which Veloudi et al. [4] make from a qualitative review of RCTs, namely that vitamin D supplementation has no effect on arterial stiffness or blood pressure. However, Rodríguez et al. [7] surmise that larger, well-designed RCTs are required to make sound conclusions on the effect of vitamin D supplementation on arterial stiffness. In terms of endothelial function, a quantitative meta-analysis published this year identified 16 RCTs [8] , the summary of which also showed no effect of vitamin D supplementation.
Such is the level of research into the field that in 2014, Theodoratou et al. [9] conducted a review of 107 systematic reviews and 74 meta-analyses on plasma vitamin D levels and vitamin D supplementation across multiple health outcomes. Here, too, the authors concluded that the current literature provides no strong evidence for beneficial effects of vitamin D supplementation. However, they again raise the limitation of a commonly short study duration and also highlight that many studies do not measure plasma vitamin D concentration, not permitting for control of vitamin D levels given that the absorption and metabolism differs between individuals.
In terms of cardiovascular events, a meta-analysis of 18 RCTs showed plausible protection against cardiac failure in older people [10] , but only with inclusion of patients with a high-risk profile of cardiovascular events. Previous studies did not show any effect on cardiovascular end points of vitamin D supplementation (51 studies) [11] . One meta-analysis of 18 RCTs identified a reduction in all-cause mortality with increased vitamin D [12] , though the included studies relied heavily on high-risk groups with osteoporosis and analysed both plasma vitamin D levels and supplementary vitamin D, and no individual study identified a positive benefit of vitamin D for mortality [13] . This lack of statistical power is consistent with a metaanalysis of 8 studies on cardiovascular disease mortality, where a trend towards reduced mortality could not be shown to be statistically significant across the analysis [14] . A more recent meta-analysis found that the effect of vitamin D supplementation on all-cause mortality was only seen for vitamin D administration of 3 years or more [15] . Of the studies identified by Veloudi et al. [4] , only 2 had a duration of 3 years or more, and this may present a major limitation in the available data on the investigation of the effect of vitamin D supplementation on blood pressure and arterial stiffness. However, Veloudi et al. [4] did attempt to address the duration of studies within the limitations of the data available by describing studies above and below a 6-month duration, with the majority of studies falling into vitamin D supplementation of less than 6 months. This supports the conclusion of Rodríguez et al. [7] that betterdesigned (and longer-duration) studies may be needed to discover any effect of vitamin D supplementation.
On the weight of the many quantitative meta-analyses of the effect of vitamin D supplementation on cardiovascular factors and end points, it can be concluded that vitamin D supplementation has no beneficial effect, and the review by Veloudi et al. [4] provides a graphical and qualitative summary of some of this evidence. Despite the number of studies on vitamin D supplementation and the number of quantitative meta-analyses of these data, it is repeatedly highlighted that the majority of studies follow a short duration that is unlikely to allow cardiovascular benefit and often do not control for circulating levels of vitamin D or vitamin D deficiency.
At this stage, the evidence indicates that short-term vitamin D supplementation imparts no cardiovascular benefit. In terms of longer-term administration of vitamin D, we are reliant on only a few studies in postmenopausal women [16] , healthy elderly men [17] and normotensive men [18] , all of which were studies that included combined calcium and vitamin D supplementation and were designed to investigate bone loss, not cardiovascular factors. Cardiovascular events have been examined in follow-up studies of 1-6 years' duration, again with the primary outcome in all studies being non-cardiovascular related [10] . Ignoring the limitations of these studies in investigating cardiovascular factors and end points, these too generally indicate no beneficial effect of vitamin D supplementation. Without a specifically designed long-term study on cardiovascular effects of vitamin D supplementation, it is difficult
